CNS PRECURSOR CELL DYSFUNCTION IN DEVELOPMENTAL MALADIES
CNS PRECURSOR CELL DYSFUNCTION IN DEVELOPMENTAL MALADIES
批准号:
6383012
负责人:
MARK D NOBLE
金额:
$32.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-01 至 2006-06-30
关键词:
cell biology cell differentiation cell population study cellular pathology central nervous system developmental neurobiology disease /disorder model endocrine disorder hormone regulation /control mechanism hormone therapy hypothyroidism intracellular iron disorder laboratory rat myelination nervous system disorder neurons nutrition disorders oligodendroglia oxidation reduction reaction pathologic process stem cell transplantation stem cells syndrome tissue /cell culture
中文摘要
许多不同的生理损伤对发育中的儿童造成长期的神经损伤,与髓鞘形成失败和/或现有髓鞘的破坏以及随后无法修复这种损伤有关。例如,这种损害与甲状腺激素缺乏、缺铁与营养不足、胎儿因缺氧发作或与放疗或化疗有关而接触酒精或可卡因有关。我们提出,许多儿童神经发育障碍的潜在细胞基础是导致中枢神经系统(CNS)分化细胞类型的前体细胞发育的特定步骤被破坏。与这一假设相一致,我们已经发现,在甲状腺激素和铁缺乏的两种特定情况下,中枢神经系统髓磷脂形成少突胶质细胞发育的特定步骤被破坏。首先,我们将对甲状腺功能减退症进行体外和体内研究,作为激素和营养缺乏症的明确模型。这些研究将提供对甲状腺激素缺乏脆弱的前体细胞发育阶段的详细地图。为了确定为什么在太晚的阶段使用激素替代疗法不能促进中枢神经系统损伤的修复,我们接下来将把确定的干细胞和前体细胞群移植到发育过程中甲状腺功能减退的动物的中枢神经系统中,并检查这些细胞对组织修复的贡献能力。这些实验将有助于我们深入了解,恢复正常发育的失败是否仅仅是由于缺乏适当的前体细胞,还是由于中枢神经系统变得难以修复。作为细胞生物学分析的补充,我们还将确定细胞内氧化还原调节是否是甲状腺激素对受其调节的所有中枢神经系统前体细胞发挥作用的机制的关键组成部分。此外,我们将扩展初步观察,表明铁缺乏的非常不同的紊乱也可能部分地通过改变细胞内氧化还原状态起作用。通过探究不同的证候是否通过重叠机制发挥作用,这些研究可能为治疗激素和营养缺乏症的潜在新治疗方法提供重要线索。总之,这项研究计划将确定细胞和生化机制,解释关键发育时期的生物学,并可能导致确定治疗方法,可以加强修复多种虚证。
英文摘要
Many different physiological insults to the developing child result in long-lasting neurological impairment associated with a failure of myelination and/or destruction of existing myelin and a subsequent inability to repair this damage. Such impairment is associated, for example, with deficiencies in thyroid hormone, iron with inadequate nutrition, with fetal exposure to alcohol or cocaine, as a result of hypoxic episodes or in association with radiotherapy or chemotherapy. We propose that the underlying cellular basis for many childhood disorders of neurological development is disruption of specific steps in the development of the precursor cells that give rise to the differentiated cell types of the central nervous system (CNS). Consistent with this hypothesis, we have discovered that specific steps in development of the myelin-forming oligodendrocytes of the CNS are disrupted in the two specific instances of thyroid hormone and iron deficiency. Initially, we will carry out in vitro and in vivo studies on hypothyroidism, as a well-defined model of hormonal and nutritional deficiency disorders. These studies will provide a detailed map of the stages of precursor cell development vulnerable to deficiency of thyroid hormone. To determine why hormonal replacement therapy applied at too late a stage does not promote repair of CNS damage, we next will transplant defined stem cell and precursor cell populations into the CNS of animals that have been hypothyroid throughout development and examine the ability of these cells to contribute to tissue repair. These experiments will provide insight into whether the failure to reconstitute normal development is due solely to an absence of appropriate precursor cells, or also is due to the CNS becoming refractory to repair. Complementary to this cellular biological analysis, we also will determine whether intracellular redox modulation is a critical component of the mechanism by which thyroid hormone exerts its effects on all the CNS precursor cells regulated by this hormone. In addition, we will extend preliminary observations indicating that the very different disorder of iron deficiency may also work in part through alteration of intracellular redox state. By asking whether different syndromes exert their effect through overlapping mechanisms, these studies may provide important clues to potential new therapeutic approaches to the treatment of hormonal and nutritional deficiency disorders. In sum, this research program will identify both cellular and biochemical mechanisms that explain the biology of critical developmental periods and may lead to the identification of therapeutic approaches that can enhance repair in multiple deficiency syndromes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism-based drug repurposing and novel treatments for glioblastoma
-
批准号:9891963
-
项目类别:
-
资助金额:$35.23万
-
财政年份:2017
-
负责人:MARK D NOBLE
-
依托单位:
Mechanism-based drug repurposing and novel treatments for glioblastoma
-
批准号:9453659
-
项目类别:
-
资助金额:$35.23万
-
财政年份:2017
-
负责人:MARK D NOBLE
-
依托单位:
CNS vulnerability to systemic chemotherapy: Causes and prevention
-
批准号:7533303
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2008
-
负责人:MARK D NOBLE
-
依托单位:
CNS vulnerability to systemic chemotherapy: Causes and prevention
-
批准号:7666255
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2008
-
负责人:MARK D NOBLE
-
依托单位:
White matter damage in Alzheimer?s disease: New cellular targets and mechanisms
-
批准号:7471948
-
项目类别:
-
资助金额:$19.64万
-
财政年份:2008
-
负责人:MARK D NOBLE
-
依托单位:
White matter damage in Alzheimer?s disease: New cellular targets and mechanisms
-
批准号:7577523
-
项目类别:
-
资助金额:$16.36万
-
财政年份:2008
-
负责人:MARK D NOBLE
-
依托单位:
CNS vulnerability to systemic chemotherapy: Causes and prevention
-
批准号:8270549
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2008
-
负责人:MARK D NOBLE
-
依托单位:
CNS vulnerability to systemic chemotherapy: Causes and prevention
-
批准号:8076398
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2008
-
负责人:MARK D NOBLE
-
依托单位:
CNS vulnerability to systemic chemotherapy: Causes and prevention
-
批准号:7878840
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2008
-
负责人:MARK D NOBLE
-
依托单位:
Low-level toxicant perturbation of neural cell function
-
批准号:7171812
-
项目类别:
-
资助金额:$35.98万
-
财政年份:2006
-
负责人:MARK D NOBLE
-
依托单位:
Low-level toxicant perturbation of neural cell function
-
批准号:7050328
-
项目类别:
-
资助金额:$37.05万
-
财政年份:2006
-
负责人:MARK D NOBLE
-
依托单位:
Low-level toxicant perturbation of neural cell function
-
批准号:7563951
-
项目类别:
-
资助金额:$35.26万
-
财政年份:2006
-
负责人:MARK D NOBLE
-
依托单位:
Low-level toxicant perturbation of neural cell function
-
批准号:7336336
-
项目类别:
-
资助金额:$35.26万
-
财政年份:2006
-
负责人:MARK D NOBLE
-
依托单位:
Low-level toxicant perturbation of neural cell function
-
批准号:7751925
-
项目类别:
-
资助金额:$34.9万
-
财政年份:2006
-
负责人:MARK D NOBLE
-
依托单位:
Oligodendrocytes & precursors: toxicity of chemotherapy
-
批准号:6464963
-
项目类别:
-
资助金额:$37.49万
-
财政年份:2002
-
负责人:MARK D NOBLE
-
依托单位:
Oligodendrocytes & precursors: toxicity of chemotherapy
-
批准号:6623348
-
项目类别:
-
资助金额:$37.41万
-
财政年份:2002
-
负责人:MARK D NOBLE
-
依托单位:
Oligodendrocytes & precursors: toxicity of chemotherapy
-
批准号:6726055
-
项目类别:
-
资助金额:$37.41万
-
财政年份:2002
-
负责人:MARK D NOBLE
-
依托单位:
Oligodendrocytes & precursors: toxicity of chemotherapy
-
批准号:6893362
-
项目类别:
-
资助金额:$37.41万
-
财政年份:2002
-
负责人:MARK D NOBLE
-
依托单位:
CNS PRECURSOR CELL DYSFUNCTION IN DEVELOPMENTAL MALADIES
-
批准号:6911500
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2001
-
负责人:MARK D NOBLE
-
依托单位:
CNS PRECURSOR CELL DYSFUNCTION IN DEVELOPMENTAL MALADIES
-
批准号:6536239
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2001
-
负责人:MARK D NOBLE
-
依托单位:
海外基金